WSPOS Myopia Consensus Statement 2025: What Parents and Practitioners Need to Know
Myopia, or nearsightedness, has become one of the most pressing pediatric health issues of our time. What used to be…
European Approval for Sydnexis’ Pediatric Myopia Treatment
Sydnexis’ SYD-101 low-dose atropine formulation is now the first pharmaceutical option in Europe for myopia. The European Commission has granted…
latest posts
